// App-Quantinova.ai

3215 : GITRL-Fc can significantly reduce tumor growth by stimulating innate and adaptive immunity

Researchers

Presenter

  • Hyun-Bae Jie

Principal Investigators

  • Minu K. Srivastava

  • Erin Mayes

  • Rui Yun

  • Fumiko Axelrod

  • Jorge Monteon

  • Austin Gurney

  • Angie In-Kyung Park

Medical Centers

  • OncoMed Pharmaceuticals Inc., Redwood City, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Natural Killer cells

  • Programmed cell death protein 1

  • Cluster of differentiation 8A

  • Type 1 T helper

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved